Target intelligence / Profile preview

O-antigen of lipopolysaccharide of Vibrio cholerae O1 or O139

Molecular classification
Polysaccharide antigen, Bacterial surface carbohydrate, Non-protein antigen, Other
01

Overview

The O-antigen of lipopolysaccharide (LPS) on Vibrio cholerae O1 and O139 is a major surface carbohydrate structure that forms the outermost part of the LPS molecule on these bacteria[1][7]. It is essential for defining the serogroup (O1 or O139), acts as a principal determinant for immune system recognition, and serves as a key virulence factor. The O-antigen consists of repeating sugar units known as O-specific polysaccharide (OSP), with the O1 serogroup O-antigen composed of repeating units of perosamine, whereas the O139 O-antigen contains a unique non-repeating hexasaccharide distinct from O1[5]. This structural difference explains why immune responses or vaccines against one serogroup do not confer protection against the other[5][9]. The O-antigen participates in bacterial evasion of host immune defenses, modulates resistance to antimicrobial peptides, serves as a receptor for bacteriophages, and is a central target for vaccine development and immune-based diagnosis[1][7][9]. Vaccines targeting the O-antigen induce protective antibodies and reduce host colonization by V. cholerae. Changes or mutations affecting O-antigen biosynthesis can attenuate virulence and compromise bacterial survival[1][10].

Other names
O-antigen of V. cholerae O1O-antigen of V. cholerae O139O-specific polysaccharide of Vibrio cholerae O1O-specific polysaccharide of Vibrio cholerae O139OSP of Vibrio cholerae O1OSP of Vibrio cholerae O139
02

Mechanism of action

Induction of O-antigen-specific antibodies (opsonization or inhibition of colonization); Target for vaccine-induced immune response (prevention of V. cholerae infection); Blocking O-antigen to neutralize pathogen or interfere with virulence

03

Biological functions

Immune evasionHost immune response stimulationSerogroup determinationVirulence factorReceptor for bacteriophage attachmentBarrier to antimicrobial peptides
04

Disease associations

InfectionHost susceptibilityVaccine targetEpidemic-associated factor
05

Safety considerations

Polysaccharide antigens have low immunogenicity in young children unless conjugated to a carrier proteinAntigenic variation between O1 and O139 may affect cross-protection and diagnostics
06

Interacting drugs

Oral cholera vaccines (e.g., vaccines containing V. cholerae O1 and O139 OSP conjugates)
07

Biomarkers

O-antigen-specific antibodies as markers of cholera exposure or immunity

Beyond the preview

Go deeper on O-antigen of lipopolysaccharide of Vibrio cholerae O1 or O139.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O-antigen of lipopolysaccharide of Vibrio cholerae O1 or O139.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call